United States · FDA National Drug Code directory
PYLERA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61269-381_b0853a86-d7e4-400b-b21b-5379fbabfe0f
- Product NDC
- 61269-381
- Form
- CAPSULE
- Composition / generic term
- BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE
- Labeler
- H2-Pharma, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250818
- Source listing expiry
- 20271231
Source-listed ingredients
- BISMUTH SUBCITRATE POTASSIUM — 140 mg/1
- METRONIDAZOLE — 125 mg/1
- TETRACYCLINE HYDROCHLORIDE — 125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 BOX (61269-381-12) / 12 CAPSULE in 1 BLISTER PACK · 61269-381-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →